Neuboron Medical Group
Xiamen, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage oncology company developing integrated Boron Neutron Capture Therapy systems for cancer.
Oncology
Technology Platform
Develops an integrated Boron Neutron Capture Therapy platform comprising accelerator neutron sources, boron-10 drugs, and treatment planning systems.
Opportunities
Potential to establish a new standard of care for localized, treatment-resistant cancers with its targeted radiotherapy platform.
Risk Factors
Regulatory and reimbursement hurdles for a complex new treatment modality, alongside the need for broad clinical validation.
Competitive Landscape
Faces limited but specialized global competition in the BNCT field, competing on system cost, accessibility, and drug performance.